SHANGHAI, March 18 (Xinhua) -- A Chinese research team has developed a multicellular scaffold based on inorganic bioceramics for treating tendon-to-bone injuries.
Restriction of motor activity due to loss of natural structure is a major cause of decreased life quality in patients suffering from tendon-to-bone injuries.
To solve this problem, the research team, led by the Shanghai Institute of Ceramics (SIC) of the Chinese Academy of Sciences, combined manganese silicate (MS) nanoparticles with tendon/bone-related cells to construct an immunomodulatory multicellular scaffold to achieve integrated tendon-to-bone regeneration.
The scaffold not only demonstrated diverse biological activities in vitro, but also achieved immune regulation, multi-tissue integration regeneration and motor function recovery in a variety of animal models of rotator cuff injury.
The study provides a new concept for achieving immunomodulation and integrated regeneration of tendon-bone and other tissue interfaces, said Wu Chengtie with the SIC, who led the research.
The study was recently published in the journal Science Advances.
(Editor:Fu Bo)
Row as Rishi Sunak lines up ex
Feature: Asian Americans pledge to fight discrimination, hate in U.S.
Mother in law of missing Kansas mom and friend arrested in huge Oklahoma SWAT raid
Biden touts progress on economy, immigration despite wide disapproval
Lala Kent pens a heartfelt tribute to her father on the sixth anniversary of his tragic passing
300,000 new families eligible for welfare program in Sri Lanka
UN chief to convene with key donors to ensure continued support for Palestine refugees relief work
I blocked off my driveway with £34 tool from Screwfix
Russia repeatedly sought peaceful solution to problems in Ukraine: Putin
Lala Kent pens a heartfelt tribute to her father on the sixth anniversary of his tragic passing
Yemen's Houthis claim launching missile attacks at U.S. commercial vessels, navy warships